Close

Inovio Pharma (INO) Announces Publication of Positive VGX-3100 Phase 2b Trial Results in HPV

September 17, 2015 8:04 AM EDT Send to a Friend
Inovio Pharmaceuticals, Inc. (INO) announced today that The Lancet, one of the world's leading medical journals, published a peer-reviewed article ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login